Csontritkulás: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• RANKL 1
• PI3K 0
• NRF2 0
• AKT 0
• CTNNB1 0
• MAPK 0
• SIRT1 0
• mTOR 0
• AMPK 0
• PPAR 0
• STAT3 0
• ERK 0
• NLRP3 0
• YAP 0
• GPX4 0
• GLP-1 1
• TP53 0
• STING 0
• TNF 0
• HIF-1 0
• JAK 0
• METTL3 0
• IL-6 0
• PTEN 0
• VEGF 0
• CXCR4 0
• JNK 0
• MMP-9 0
• ESR1 0
• IL-4 0
• MEK 0
• PINK1 0
• SGLT2 0
• APP 0
• COX-2 0
• CSF1R 0
• DPP-4 0
• FTO 0
• HMGB1 0
• IL-1 0
• KIT 1
• APOE 0
• CD40 0
• CGRP 0
• EGFR 0
• EZH2 0
• FOXP3 0
• MYC 0
• TFEB 0
• ACE2 0
• AXL 0
• BRAF 0
• BRCA1 0
• BRCA2 0
• BRD4 0
• CCR5 0
• CDK4/6 0
• FGFR 0
• G6PD 0
• HSP90 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-ERC

  Extending Female Reproductive Longevity: Neurovascular Control of the Ovarian Reserve (dOvary)

  Academisch Ziekenhuis Leiden· Leiden, Hollandia· EU contribution 2 500 000 EUR· until 2031. okt.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Predicting Effective Plant Phosphopeptide–Calcium Formulations Using Machine Learning for Ca/Vitamin D3 and K2 Supplement Development via Pickering Emulsion (CaVita-Phos)

  Christian-Albrechts-Universitaet Zu Kiel· Kiel, Németország· EU contribution 202 125 EUR· until 2028. szept.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  A Human Muscle-Bone Organoid-on-Chip to Study Bone Mechano- Adaptation via Optogenetic Control (BONE-TUNE)

  Eidgenoessische Technische Hochschule Zuerich· Zuerich, Svájc· EU contribution 292 119 EUR· until 2028. jún.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Hypothalamic cell changes during menopause: the neuroendocrine origin of its metabolic alterations (HypoPause)

  Universidad de Santiago de Compostela· Santiago De Compostela, Spanyolország· EU contribution 1 498 325 EUR· until 2031. jan.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  EVOLUTIONARY MECHANISMS OF AGE-RELATED BONE LOSS ACROSS THE HUMAN AND HOMINID SKELETON (STAND UP)

  Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev· Munchen, Németország· EU contribution 401 232 EUR· until 2028. dec.· 3 countries

5 of 26 running projects, newest first. Listed amounts together: 61,7 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• GLP-1R Actions on Muscle and the Skeleton

  NCT07154719· Pennington Biomedical Research Center· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 17
• Organoids 1
• Mendelian Randomization Analysis 90
• CRISPR-Cas Systems 1
• Gene Expression Profiling 60
• Sequence Analysis, RNA 5
• Whole Genome Sequencing 1
• Exome Sequencing 6
• Proteomics 23
• Metabolomics 25
• Mass Spectrometry 7
• Flow Cytometry 6
• Immunohistochemistry 10
• Xenograft Model Antitumor Assays 3
• Magnetic Resonance Imaging 73
• Machine Learning 79
• Deep Learning 38
• Cohort Studies 236
• Genome-Wide Association Study 83

• Role of metabolites in mediating the effect of lipidomes on osteoporosis: A Mendelian randomization study.

  Medicine (Baltimore), 2026. nov.

• Unraveling the shared genetic architecture of metabolic bone diseases via genomic structural equation modeling and multi-omics integration.

  PLoS One, 2026. okt.

• Integrative Genomic Evidence for a Putative Causal Association Between Latent Epigenetic Ageing and Bone Mineral Density via Monocyte-Mediated Gene Regulation.

  Calcif Tissue Int, 2026. okt.

• Genetic Liability to Psychiatric Disorder and Risk of Musculoskeletal Diseases: A Bidirectional Mendelian Randomization Study.

  Actas Esp Psiquiatr, 2026. okt.

• Shared genetic basis of sarcopenia and osteoporosis: insights from GWAS and multi-omics analyses.

  J Bone Miner Metab, 2026. szept.

• Osteoporosis genetic risk prediction using bone mineral density polygenic scores in Japanese: TMM CommCohort study.

  J Hum Genet, 2026. szept.

• Associations between coeliac disease and musculoskeletal conditions: epidemiology and genetic evidence from a large-scale cohort study.

  Clin Rheumatol, 2026. aug.

• Exploring the causal relationship and pathogenesis of intracranial aneurysms with osteoporosis based on Mendelian randomization and bioinformatics study.

  J Bone Miner Metab, 2026. aug.

• Genetic Evidence for Causal Effects of Domain-Specific Physical Activity and Sedentary Behavior on Osteoporosis and Inflammatory Arthritis: A Bidirectional Mendelian Randomization Study.

  Genes (Basel), 2026. aug.

• Association of rs3736228 polymorphism in LRP5 gene with bone fracture and osteoporosis: a systematic review and updated meta-analysis.

  BMC Musculoskelet Disord, 2026. júl.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.